Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 53

1.

Peripheral nerve field stimulation in medically refractory trigeminal neuralgia attributed to multiple sclerosis.

Klein J, Siepmann T, Schackert G, Ziemssen T, Juratli TA.

J Neurosurg. 2020 Mar 20:1-7. doi: 10.3171/2019.12.JNS192261. [Epub ahead of print]

PMID:
32197243
2.

Poor prognosis associated with TERT gene alterations in meningioma is independent of the WHO classification: an individual patient data meta-analysis.

Mirian C, Duun-Henriksen AK, Juratli T, Sahm F, Spiegl-Kreinecker S, Peyre M, Biczok A, Tonn JC, Goutagny S, Bertero L, Maier AD, Møller Pedersen M, Law I, Broholm H, Cahill DP, Brastianos P, Poulsgaard L, Fugleholm K, Ziebell M, Munch T, Mathiesen T.

J Neurol Neurosurg Psychiatry. 2020 Apr;91(4):378-387. doi: 10.1136/jnnp-2019-322257. Epub 2020 Feb 10. Review.

PMID:
32041819
3.

Genomic Analysis of Posterior Fossa Meningioma Demonstrates Frequent AKT1 E17K Mutations in Foramen Magnum Meningiomas.

Williams SR, Juratli TA, Castro BA, Lazaro TT, Gill CM, Nayyar N, Strickland MR, Babinski M, Johnstone SE, Frosch MP, Silverman IM, Ely HA, Kaplan AB, D'Andrea MR, Bihun IV, Hoang K, Batchelor E, Christiansen J, Cahill DP, Barker FG 2nd, Brastianos PK.

J Neurol Surg B Skull Base. 2019 Dec;80(6):562-567. doi: 10.1055/s-0038-1676821. Epub 2019 Jan 10.

PMID:
31750041
4.

In Reply: A Clinical Rule for Preoperative Prediction of BRAF Mutation Status in Craniopharyngiomas.

Fujio S, Juratli TA, Cahill DP, Barker FG, Brastianos PK.

Neurosurgery. 2019 Nov 1;85(5):E966. doi: 10.1093/neuros/nyz327. No abstract available.

5.

Targeted treatment of papillary craniopharyngiomas harboring BRAF V600E mutations.

Juratli TA, Jones PS, Wang N, Subramanian M, Aylwin SJB, Odia Y, Rostami E, Gudjonsson O, Shaw BL, Cahill DP, Galanis E, Barker FG 2nd, Santagata S, Brastianos PK.

Cancer. 2019 Sep 1;125(17):2910-2914. doi: 10.1002/cncr.32197. Epub 2019 Jul 17. No abstract available.

PMID:
31314136
6.

TERT Alterations in Progressive Treatment-Resistant Meningiomas.

Juratli TA, Brastianos PK, Cahill DP.

Neurosurgery. 2018 Sep 1;65(CN_suppl_1):66-68. doi: 10.1093/neuros/nyy154. No abstract available.

PMID:
31076787
7.

PI3K/AKT/mTOR Pathway Alterations Promote Malignant Progression and Xenograft Formation in Oligodendroglial Tumors.

Tateishi K, Nakamura T, Juratli TA, Williams EA, Matsushita Y, Miyake S, Nishi M, Miller JJ, Tummala SS, Fink AL, Lelic N, Koerner MVA, Miyake Y, Sasame J, Fujimoto K, Tanaka T, Minamimoto R, Matsunaga S, Mukaihara S, Shuto T, Taguchi H, Udaka N, Murata H, Ryo A, Yamanaka S, Curry WT, Dias-Santagata D, Yamamoto T, Ichimura K, Batchelor TT, Chi AS, Iafrate AJ, Wakimoto H, Cahill DP.

Clin Cancer Res. 2019 Jul 15;25(14):4375-4387. doi: 10.1158/1078-0432.CCR-18-4144. Epub 2019 Apr 11.

PMID:
30975663
8.

Accelerated progression of IDH mutant glioma after first recurrence.

Miller JJ, Loebel F, Juratli TA, Tummala SS, Williams EA, Batchelor TT, Arrillaga-Romany I, Cahill DP.

Neuro Oncol. 2019 May 6;21(5):669-677. doi: 10.1093/neuonc/noz016.

PMID:
30668823
9.

Glioblastoma multiforme presenting as postpartum depression: a case report.

Petzold J, Severus E, Meyer S, Bauer M, Daubner D, Krex D, Juratli TA.

J Med Case Rep. 2018 Dec 20;12(1):374. doi: 10.1186/s13256-018-1909-3.

10.

Radiographic assessment of contrast enhancement and T2/FLAIR mismatch sign in lower grade gliomas: correlation with molecular groups.

Juratli TA, Tummala SS, Riedl A, Daubner D, Hennig S, Penson T, Zolal A, Thiede C, Schackert G, Krex D, Miller JJ, Cahill DP.

J Neurooncol. 2019 Jan;141(2):327-335. doi: 10.1007/s11060-018-03034-6. Epub 2018 Dec 7.

11.

A Clinical Rule for Preoperative Prediction of BRAF Mutation Status in Craniopharyngiomas.

Fujio S, Juratli TA, Arita K, Hirano H, Nagano Y, Takajo T, Yoshimoto K, Bihun IV, Kaplan AB, Nayyar N, Fink AL, Bertalan MS, Tummala SS, Curry WT Jr, Jones PS, Martinez-Lage M, Cahill DP, Barker FG, Brastianos PK.

Neurosurgery. 2019 Aug 1;85(2):204-210. doi: 10.1093/neuros/nyy569.

PMID:
30481321
12.

TERT promoter wild-type glioblastomas show distinct clinical features and frequent PI3K pathway mutations.

Williams EA, Miller JJ, Tummala SS, Penson T, Iafrate AJ, Juratli TA, Cahill DP.

Acta Neuropathol Commun. 2018 Oct 17;6(1):106. doi: 10.1186/s40478-018-0613-2.

13.

DMD genomic deletions characterize a subset of progressive/higher-grade meningiomas with poor outcome.

Juratli TA, McCabe D, Nayyar N, Williams EA, Silverman IM, Tummala SS, Fink AL, Baig A, Martinez-Lage M, Selig MK, Bihun IV, Shankar GM, Penson T, Lastrapes M, Daubner D, Meinhardt M, Hennig S, Kaplan AB, Fujio S, Kuter BM, Bertalan MS, Miller JJ, Batten JM, Ely HA, Christiansen J, Baretton GB, Stemmer-Rachamimov AO, Santagata S, Rivera MN, Barker FG 2nd, Schackert G, Wakimoto H, Iafrate AJ, Carter SL, Cahill DP, Brastianos PK.

Acta Neuropathol. 2018 Nov;136(5):779-792. doi: 10.1007/s00401-018-1899-7. Epub 2018 Aug 19.

PMID:
30123936
14.

Genotype-targeted local therapy of glioma.

Shankar GM, Kirtane AR, Miller JJ, Mazdiyasni H, Rogner J, Tai T, Williams EA, Higuchi F, Juratli TA, Tateishi K, Koerner MVA, Tummala SS, Fink AL, Penson T, Schmidt SP, Wojtkiewicz GR, Baig A, Francis JM, Rinne ML, Batten JM, Batchelor TT, Brastianos PK, Curry WT Jr, Barker FG 2nd, Jordan JT, Iafrate AJ, Chi AS, Lennerz JK, Meyerson M, Langer R, Wakimoto H, Traverso G, Cahill DP.

Proc Natl Acad Sci U S A. 2018 Sep 4;115(36):E8388-E8394. doi: 10.1073/pnas.1805751115. Epub 2018 Aug 6.

15.

TERT Promoter Mutation Detection in Cell-Free Tumor-Derived DNA in Patients with IDH Wild-Type Glioblastomas: A Pilot Prospective Study.

Juratli TA, Stasik S, Zolal A, Schuster C, Richter S, Daubner D, Juratli MA, Thowe R, Hennig S, Makina M, Meinhardt M, Lautenschlaeger T, Schackert G, Krex D, Thiede C.

Clin Cancer Res. 2018 Nov 1;24(21):5282-5291. doi: 10.1158/1078-0432.CCR-17-3717. Epub 2018 Jun 25.

16.

IDH1 mutation in human glioma induces chemical alterations that are amenable to optical Raman spectroscopy.

Uckermann O, Yao W, Juratli TA, Galli R, Leipnitz E, Meinhardt M, Koch E, Schackert G, Steiner G, Kirsch M.

J Neurooncol. 2018 Sep;139(2):261-268. doi: 10.1007/s11060-018-2883-8. Epub 2018 May 14.

PMID:
29761368
17.

A Systematic Review of the Semi-Sitting Position in Neurosurgical Patients with Patent Foramen Ovale: How Frequent Is Paradoxical Embolism?

Klein J, Juratli TA, Weise M, Schackert G.

World Neurosurg. 2018 Jul;115:196-200. doi: 10.1016/j.wneu.2018.04.114. Epub 2018 Apr 26. Review.

PMID:
29704690
18.

Intratumoral heterogeneity and TERT promoter mutations in progressive/higher-grade meningiomas.

Juratli TA, Thiede C, Koerner MVA, Tummala SS, Daubner D, Shankar GM, Williams EA, Martinez-Lage M, Soucek S, Robel K, Penson T, Krause M, Appold S, Meinhardt M, Pinzer T, Miller JJ, Krex D, Ely HA, Silverman IM, Christiansen J, Schackert G, Wakimoto H, Kirsch M, Brastianos PK, Cahill DP.

Oncotarget. 2017 Nov 24;8(65):109228-109237. doi: 10.18632/oncotarget.22650. eCollection 2017 Dec 12.

19.

Optical Analysis of Glioma: Fourier-Transform Infrared Spectroscopy Reveals the IDH1 Mutation Status.

Uckermann O, Juratli TA, Galli R, Conde M, Wiedemuth R, Krex D, Geiger K, Temme A, Schackert G, Koch E, Steiner G, Kirsch M.

Clin Cancer Res. 2018 Jun 1;24(11):2530-2538. doi: 10.1158/1078-0432.CCR-17-1795. Epub 2017 Dec 19.

20.

Molecular pathogenesis and therapeutic implications in pediatric high-grade gliomas.

Juratli TA, Qin N, Cahill DP, Filbin MG.

Pharmacol Ther. 2018 Feb;182:70-79. doi: 10.1016/j.pharmthera.2017.08.006. Epub 2017 Aug 19. Review.

PMID:
28830841
21.

Probabilistic Tractography of the Cranial Nerves in Vestibular Schwannoma.

Zolal A, Juratli TA, Podlesek D, Rieger B, Kitzler HH, Linn J, Schackert G, Sobottka SB.

World Neurosurg. 2017 Nov;107:47-53. doi: 10.1016/j.wneu.2017.07.102. Epub 2017 Jul 25.

PMID:
28754643
22.

Safety and Effectiveness of Bis-Chloroethylnitrosourea Wafer Chemotherapy in Elderly Patients with Recurrent Glioblastoma.

Klein J, Juratli TA, Radev Y, Daubner D, Soucek S, Schackert G, Krex D.

Oncology. 2017;93(1):43-50. doi: 10.1159/000464464. Epub 2017 Apr 11.

PMID:
28395288
23.

[Chronic subdural hematoma in the elderly].

Juratli TA, Klein J, Schackert G.

Chirurg. 2017 Feb;88(2):131-135. doi: 10.1007/s00104-016-0343-6. Review. German.

PMID:
28054113
24.

Comparison of probabilistic and deterministic fiber tracking of cranial nerves.

Zolal A, Sobottka SB, Podlesek D, Linn J, Rieger B, Juratli TA, Schackert G, Kitzler HH.

J Neurosurg. 2017 Sep;127(3):613-621. doi: 10.3171/2016.8.JNS16363. Epub 2016 Dec 16.

PMID:
27982771
25.

Targeted sequencing of SMO and AKT1 in anterior skull base meningiomas.

Strickland MR, Gill CM, Nayyar N, D'Andrea MR, Thiede C, Juratli TA, Schackert G, Borger DR, Santagata S, Frosch MP, Cahill DP, Brastianos PK, Barker FG 2nd.

J Neurosurg. 2017 Aug;127(2):438-444. doi: 10.3171/2016.8.JNS161076. Epub 2016 Nov 25.

PMID:
27885953
26.

Real-Time Label-Free Embolus Detection Using In Vivo Photoacoustic Flow Cytometry.

Juratli MA, Menyaev YA, Sarimollaoglu M, Siegel ER, Nedosekin DA, Suen JY, Melerzanov AV, Juratli TA, Galanzha EI, Zharov VP.

PLoS One. 2016 May 26;11(5):e0156269. doi: 10.1371/journal.pone.0156269. eCollection 2016.

27.

[Surgery for metastases, anatomical and ethical limits. Special aspect: oligometastases].

Perrakis A, Juratli TA, Hohenberger W, Croner RS, Schackert G.

Chirurg. 2016 Mar;87(3):208-15. doi: 10.1007/s00104-015-0147-0. Review. German.

PMID:
26857002
28.

Enhancing tumor apparent diffusion coefficient histogram skewness stratifies the postoperative survival in recurrent glioblastoma multiforme patients undergoing salvage surgery.

Zolal A, Juratli TA, Linn J, Podlesek D, Sitoci Ficici KH, Kitzler HH, Schackert G, Sobottka SB, Rieger B, Krex D.

J Neurooncol. 2016 May;127(3):551-7. doi: 10.1007/s11060-016-2063-7. Epub 2016 Jan 30.

PMID:
26830088
29.

[Neuroradiological diagnosis and treatment of spontaneous intracranial hypotension].

Daubner D, Juratli TA, Engellandt K, Kitzler HH, Linn J.

Rofo. 2016 Feb;188(2):119-22. doi: 10.1055/s-0041-104200. Epub 2016 Jan 27. German. No abstract available.

PMID:
26815119
30.

Distribution and prognostic relevance of tumor-infiltrating lymphocytes (TILs) and PD-1/PD-L1 immune checkpoints in human brain metastases.

Harter PN, Bernatz S, Scholz A, Zeiner PS, Zinke J, Kiyose M, Blasel S, Beschorner R, Senft C, Bender B, Ronellenfitsch MW, Wikman H, Glatzel M, Meinhardt M, Juratli TA, Steinbach JP, Plate KH, Wischhusen J, Weide B, Mittelbronn M.

Oncotarget. 2015 Dec 1;6(38):40836-49. doi: 10.18632/oncotarget.5696.

31.

Daily drained CSF volume is a predictor for shunt dependence - A retrospective study.

Zolal A, Juratli T, Dengl M, Ficici KH, Schackert G, Sobottka SB.

Clin Neurol Neurosurg. 2015 Nov;138:147-50. doi: 10.1016/j.clineuro.2015.08.021. Epub 2015 Aug 28.

PMID:
26342208
32.

Impact of waiting time after surgery and overall time of postoperative radiochemotherapy on treatment outcome in glioblastoma multiforme.

Seidlitz A, Siepmann T, Löck S, Juratli T, Baumann M, Krause M.

Radiat Oncol. 2015 Aug 16;10:172. doi: 10.1186/s13014-015-0478-5.

33.

Peripheral nerve field stimulation for trigeminal neuralgia, trigeminal neuropathic pain, and persistent idiopathic facial pain.

Klein J, Sandi-Gahun S, Schackert G, Juratli TA.

Cephalalgia. 2016 Apr;36(5):445-53. doi: 10.1177/0333102415597526. Epub 2015 Jul 24.

PMID:
26209705
34.

[Neurofibromatosis type 1 associated spinal arteriovenous fistula - treatment with primary endovascular coiling].

Daubner D, Mucha D, Juratli TA, Leimert M, Gerber JC.

Rofo. 2015 Dec;187(12):1130-2. doi: 10.1055/s-0035-1553147. Epub 2015 Jun 17. German. No abstract available.

PMID:
26085178
35.

A five year-old child with clear cell petro-clival meningioma: case report with clinical and histopathological long-term follow-up.

Juratli TA, Geiger KD, Weigel P, von der Hagen M, Daubner D, Pinzer T, Hahn G, Schackert G, Kirsch M.

Childs Nerv Syst. 2015 Nov;31(11):2193-8. doi: 10.1007/s00381-015-2782-7. Epub 2015 Jun 16.

PMID:
26077595
36.

Radio-chemotherapy improves survival in IDH-mutant, 1p/19q non-codeleted secondary high-grade astrocytoma patients.

Juratli TA, Lautenschläger T, Geiger KD, Pinzer T, Krause M, Schackert G, Krex D.

J Neurooncol. 2015 Sep;124(2):197-205. doi: 10.1007/s11060-015-1822-1. Epub 2015 Jun 2.

PMID:
26033545
37.

Determining optimal treatment strategy for diffuse glioma: the emerging role of IDH mutations.

Juratli TA, Cahill DP, McCutcheon IE.

Expert Rev Anticancer Ther. 2015 Jun;15(6):603-6. doi: 10.1586/14737140.2015.1047351. Epub 2015 May 17.

38.

[Acute treatment of patients with severe traumatic brain injury].

Juratli TA, Stephan SE, Stephan AE, Sobottka SB.

Anaesthesist. 2015 Feb;64(2):159-74. doi: 10.1007/s00101-014-2337-4. Review. German.

PMID:
25608499
39.

Percutaneous pedicle screw and rod fixation with TLIF in a series of 14 patients with recurrent lumbar disc herniation.

Niesche M, Juratli TA, Sitoci KH, Neidel J, Daubner D, Schackert G, Leimert M.

Clin Neurol Neurosurg. 2014 Sep;124:25-31. doi: 10.1016/j.clineuro.2014.06.020. Epub 2014 Jun 23.

PMID:
24999541
40.

Early hemorrhagic progression of traumatic brain contusions: frequency, correlation with coagulation disorders, and patient outcome: a prospective study.

Juratli TA, Zang B, Litz RJ, Sitoci KH, Aschenbrenner U, Gottschlich B, Daubner D, Schackert G, Sobottka SB.

J Neurotrauma. 2014 Sep 1;31(17):1521-7. doi: 10.1089/neu.2013.3241. Epub 2014 Jul 8.

PMID:
24738836
41.

[Differential diagnoses of brain tumors around the forth ventricle].

Juratli TA, Daubner D, Engellandt K, von Kummer R, Hahn G, Schackert G, Pinzer T.

Rofo. 2014 Jan;186(1):1-4. doi: 10.1055/s-0033-1346862. Epub 2013 Dec 20. German. No abstract available.

PMID:
24363226
42.

Is there pseudoprogression in secondary glioblastomas?

Juratli TA, Engellandt K, Lautenschlaeger T, Geiger KD, von Kummer R, Cerhova J, Chakravarti A, Krex D, Schackert G.

Int J Radiat Oncol Biol Phys. 2013 Dec 1;87(5):1094-9. doi: 10.1016/j.ijrobp.2013.09.036.

43.

An extremely rare, remote intracerebral metastasis of oral cavity cancer: a case report.

Leimert M, Juratli TA, Lindner C, Geiger KD, Gerber J, Schackert G, Kirsch M.

Case Rep Med. 2013;2013:257046. doi: 10.1155/2013/257046. Epub 2013 Oct 7.

44.

Atypical Central Neurocytoma with Recurrent Spinal Dissemination over a Period of 20 Years: A Case Report and Review of the Literature.

Juratli TA, Geiger K, Leimert M, Schackert G, Kirsch M.

Case Rep Neurol Med. 2013;2013:925647. doi: 10.1155/2013/925647. Epub 2013 Jun 9.

45.

[Differential Diagnosis of Intrasellar and Suprasellar Neoplasia ].

Daubner D, Juratli TA, Engellandt K, von Kummer R, Hahn G, Schackert G, Pinzer T.

Rofo. 2013 Jun;185(6):515-20. doi: 10.1055/s-0032-1319443. Epub 2013 Jun 5. German. No abstract available.

PMID:
23740700
46.

Current status of local therapy in malignant gliomas--a clinical review of three selected approaches.

Juratli TA, Schackert G, Krex D.

Pharmacol Ther. 2013 Sep;139(3):341-58. doi: 10.1016/j.pharmthera.2013.05.003. Epub 2013 May 18. Review.

PMID:
23694764
47.

Anticoagulation management of myocardial infarction after deep brain stimulation: a comparison of two cases.

Polanski W, Koy J, Juratli T, Wolz M, Klingelhöfer L, Fauser M, Storch A, Schackert G, Sobottka SB.

Acta Neurochir (Wien). 2013 Sep;155(9):1661-5; discussion 1664-5. doi: 10.1007/s00701-013-1679-z. Epub 2013 Apr 7.

PMID:
23563744
48.

Accumulation of 2-hydroxyglutarate is not a biomarker for malignant progression in IDH-mutated low-grade gliomas.

Juratli TA, Peitzsch M, Geiger K, Schackert G, Eisenhofer G, Krex D.

Neuro Oncol. 2013 Jun;15(6):682-90. doi: 10.1093/neuonc/not006. Epub 2013 Feb 14.

49.

A newly developed drill with a polished tip for the anterior cervical approach in spinal canal stenosis: a technical note.

Leimert M, Bostelmann R, Juratli TA, Mikulin HD, Herrmann B, Schackert G, Reitemeier B.

Eur Spine J. 2013 Apr;22(4):809-12. doi: 10.1007/s00586-012-2572-9. Epub 2012 Nov 22.

50.

[Rupture of an intracranial mature teratoma].

Daubner D, Juratli TA, Engellandt K.

Rofo. 2013 Jan;185(1):71-3. doi: 10.1055/s-0032-1313212. Epub 2012 Sep 21. German. No abstract available. Erratum in: Rofo. 2013 Jan;185(1):E2.

PMID:
23023226

Supplemental Content

Loading ...
Support Center